Preference and grading by operating surgeons for maxillectomies in mucormycosis cases
Original research
Keywords:
COVID-19, mucormycosis, fungal sinusitisAbstract
Aim: The purpose of the present research was to assess the preference as well as grading of maxillectomies in the Mucormycosis cases by operating surgeons. Methodology: An observational study conducted among 43 cases of confirmed CAM which included 35 males and 8 females, with an average age of 56 years. The surgical approach adopted in our cases included endoscopic surgical debridement with Denker’s approach including mandatory pterygopalatine and infratemporal fossa exploration. All cases were intraoperatively scored using our designed intraoperative scoring assessment tool for mucormycosis. Postoperatively patient recovery was assessed using C reactive protein levels and weekly imaging. Results: Although an early observation in the post op period we observed higher mortality among cases reporting with high scores as per our intraoperative reporting system. At the end of 2 months of completed treatment we report 6 cases of mortality among whom 5 cases were found to have scores (>25) and one reported with a score of 18. Conclusion: This assessment helped to grade the disease severity and also gives an insight about the postoperative prognosis too.
Downloads
References
Binder U, Maurer E, Lass-Flo¨rl C (2014) Mucormycosis–from the pathogens to the disease. Clin Microbiol Infect 20(Suppl 6):60–66.
Chamilos G, Lewis RE, Kontoyiannis DP (2008) Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503–509.
Chander J, Kaur M, Singla N (2018) Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi 4(2):46.
Chandramouli MP, Sankaranarayanan G, Prasanna RV (2018) Imaging in Rhino-OrbitaL Mucormycosis. J Evol Med Dental Sci-Jemds 7(11):1385–1390.
Chang, M. O., Labaut, B. Y. R., March, G. R., & Serrano, E. R. O. (2021). Psychological impact of COVID-19 on the sports population from Santiago. International Journal of Life Sciences, 5(3), 140–147. https://doi.org/10.29332/ijls.v5n3.1577
Gamaletsou MN, Sipsas NV, Roilides E, Walsh TJ (2012) Rhinoorbital-cerebral mucormycosis. Cur Infect Dis Rep 14(4):423–34.
Herna´ndez JL, Buckley CJ. Mucormycosis. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2021 Jan-. Available from: https://www.nc bi.nlm.nih.gov/books/NBK544364/
Herna´ndez OP, Calleros HM, Daguerre GS, Gonza´lez AS (2015) Rhino-orbito-cerebral mucormycosis. Management strategies to avoid or limit intracraneal affection and improve survival. Acta Otorrinolaringologica 66(6):348–52.
Jeong W, Keighley C, Wolfe R (2019) The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 25:26–34.
Lee AS, Lee PW, Allworth A, Smith T, Sullivan TJ (2020) Orbital mycoses in an adult subtropical population. Eye 34(9):1640–1647.
Mane R, Patil B, Mohite A, Mohanty R (2019) Facial nerve palsy: an unusual presentation in patients with rhino cerebral mucormycosis. Ind J Otolaryngol Head Neck Surg 71(3):2110–2113.
Mane RS, Watve JK, Mohite AA, Patil BC (2007) Rhinocerebral mucormycosis: a deadly disease on the rise. Ind J Otolaryngol Head Neck Surg 59(2):112–5.
Peterson KL, Wang M, Canalis RF, Abemayor E (1997) Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 107(7):855–862.
Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi 5:26.
Reid G, Lynch JP 3rd, Fishbein MC, Clark NM (2020) Mucormycosis. Semin Respir Crit Care Med 41(1):99–114.
Shah K, Dave V, Bradoo R, Shinde C, Prathibha M (2019) Orbital exenteration in rhino-orbito-cerebral mucormycosis: a prospective analytical study with scoring system. Ind J Otolaryngol Head Neck Surg 71(2):259–265.
Sudarmo, S. (2020). Leadership and human resource management: response to the COVID-19 outbreak . International Research Journal of Management, IT and Social Sciences, 7(6), 167-174. https://doi.org/10.21744/irjmis.v7n6.1033
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Vehreschild JJ, Vehreschild MJ, Mellinghoff SC, Vehreschild JJ. (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium.
Werthman-Ehrenreich A (2021) Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med 1(42):264-e5.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
